| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.38 | 0.09 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.09 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |